arrow
D

David A. Rider

agency for science technology & research (a*star)
H指数:17
被引数:1,195

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease

SLN360的临床前评估,一种针对LPA的新型siRNA,用于解决心血管疾病中脂蛋白 (a) 升高的问题

2022-05-0144
PRE
FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis
2020-02-2763
OA
Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1
MABS
IF7.3
2015-01-1463
OAAI